Participation in the study
Please, pay attention to the following important recommendations
PI and Codes
Each patient will be given a unique order number when entering data, combining the Center Code with a consecutive number. For example, if your Center Code is "CUN" (Clinica Universidad de Navarra), patients will be numbered as CUN1, CUN2, CUN3, and so on.
​
Only one Principal Investigator (PI) can be included per center;
​
​
Online Questionnaire
Use the online questionnaire accessible through the following link for data collection https://forms.gle/AT5Je5NjmgQcTZzRA
​
We anticipate completing one case will take approximately 30 minutes, especially in the initial phase.
​Continuous Communication:
Feel free to reach out to us anytime. We will maintain periodic communication with investigators, and as the principal investigator, I am available for any queries via email (lchiva@unav.es) or WhatsApp (+34630232947).
Center code and PI
​
Our data collection phase kicks off on January 1st, 2024 and each institution will be assigned to a particular CENTER CODE.
Each patient will be given a unique order number when entering data, combining the Center Code with a consecutive number. For example, if your Center Code is "CUN" (Clinica Universidad de Navarra), patients will be numbered as CUN1, CUN2, CUN3, and so on.
Only one Principal Investigator (PI) per center can be included .
While only one principal investigator is allowed per center, there is the option to consider including a second investigator. The latter may be granted a certificate of participation in the study, although they will not be eligible for authorship. Contact the central principal investigator if necessary.
Please, be very cautious while collecting data
We kindly ask for your attention to the following important recommendations to ensure the accuracy and success of our research:
​
Thorough Patient Search:
We recommend conducting a comprehensive search for all ovarian cancer patients who underwent surgery in 2018 and 2019, adhering to the specified inclusion and exclusion criteria.
​
Please try to include all eligible cases and avoid dismissing any potentially relevant ones.
​
Careful Review of Data: Take the time to meticulously review all imaging and pathological data that have been requested.
Essential Dates: Accurate outcomes depend on precise information about the dates of surgery, first relapse, and last contact or death. Please ensure accuracy in reporting these critical dates.
Online questionnaire
Use the online questionnaire accessible through the following link for request to participate in the study:
https://forms.gle/irfKWdob3CcwCEFB6
​
Once you have completed the registration form, we will send you the specifications, codes, and the Case Report form to fill out: CASE REPORT FORM.
​
We anticipate completing one case will take approximately 30 minutes, especially in the initial phase.
​
Confirmation and Record
Upon submitting a complete case form, you will receive an email confirming your submission and a copy of your response.
You can re-edit your answers later if necessary, so please ensure the required items are filled out before submission.
Continuous Communication
Feel free to reach out to us anytime. We will maintain periodic communication with investigators, and as the principal investigators, we are available for any queries via email (lchiva@unav.es or pordascerna@unav.es)
Ethics Approval Document
​
The attached Ethics Committee Approval Document is essential for securing approval to submit cases for our study.
​
While some centers may require approval only where data is collected, we highly recommend obtaining endorsement from the ethics committee at each center.
You can opt for formal approval or a Waiver Statement based on your center's policies. Feel free to reach out for clarification. Thank you for your commitment to upholding ethical standards.
​
Timely Submission
We aim to complete data collection within five months and sincerely appreciate your efforts in submitting cases at your earliest convenience.
The deadline for submission will be on June 1st 2024
​
Publications Policy
Our primary objective is to ensure that every contributor to our study receives proper credit in the publications. We aim to include as many authors as possible, maintaining order and considering the number of cases. We want everyone involved to feel acknowledged, even if they're not listed as authors, and to be recognized in Pubmed searches, as we have done in previous studies.
For all individuals who collaborate, we will issue a certificate acknowledging their participation in the Surova Study Group. This certificate can be included in their curriculum vitae as evidence of their investigator role in the trial.